Cargando…

SPAK Deficiency Corrects Pseudohypoaldosteronism II Caused by WNK4 Mutation

Stimulation of the OSR1 (Oxidative stress-responsive kinase-1)/SPAK [STE20 (sterile 20)/SPS1-related proline/alanine-rich kinase]-NCC (Na(+)-Cl(−) cotransporter) signaling cascade plays an important role in the WNK [With-No-Lysine (K)] kinase 4 D561A knock-in mouse model of pseudohypoaldosteronism t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Pei-Yi, Cheng, Chih-Jen, Wu, Yi-Chang, Fang, Yu-Wei, Chau, Tom, Uchida, Shinichi, Sasaki, Sei, Yang, Sung-Sen, Lin, Shih-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770638/ https://www.ncbi.nlm.nih.gov/pubmed/24039833 http://dx.doi.org/10.1371/journal.pone.0072969

Ejemplares similares

Consequences of SPAK inactivation on Hyperkalemic Hypertension caused by WNK1 mutations: evidence for differential roles of WNK1 and WNK4
por: Rafael, Chloé, et al.
Publicado: (2018)

Chronic Metabolic Acidosis Activates Renal Tubular Sodium Chloride Cotransporter through Angiotension II-dependent WNK4-SPAK Phosphorylation Pathway
por: Fang, Yu-Wei, et al.
Publicado: (2016)

Role of the WNK-activated SPAK kinase in regulating blood pressure
por: Rafiqi, Fatema H, et al.
Publicado: (2010)

A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4
por: Sakoh, Takashi, et al.
Publicado: (2019)

SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation
por: Thastrup, Jacob O., et al.
Publicado: (2011)

Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke
por: Josiah, Sunday Solomon, et al.
Publicado: (2021)

Aldosterone does not require angiotensin II to activate NCC through a WNK4–SPAK–dependent pathway
por: van der Lubbe, Nils, et al.
Publicado: (2012)

The WNK-SPAK/OSR1 Kinases and the Cation-Chloride Cotransporters as Therapeutic Targets for Neurological Diseases
por: Huang, Huachen, et al.
Publicado: (2019)

SPAK Deficiency Attenuates Chemotherapy-Induced Intestinal Mucositis
por: Huang, Tien-Yu, et al.
Publicado: (2021)

Generation and analysis of knock-in mice carrying pseudohypoaldosteronism type II-causing mutations in the cullin 3 gene
por: Araki, Yuya, et al.
Publicado: (2015)

The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K(+)–Cl(−) co-transporters
por: delos Heros, Paola, et al.
Publicado: (2014)

WNK4 is the major WNK positively regulating NCC in the mouse kidney
por: Takahashi, Daiei, et al.
Publicado: (2014)

Staurosporine and NEM mainly impair WNK-SPAK/OSR1 mediated phosphorylation of KCC2 and NKCC1
por: Zhang, Jinwei, et al.
Publicado: (2020)

Expression of the kidney anion exchanger 1 affects WNK4 and SPAK phosphorylation and results in claudin-4 phosphorylation
por: Lashhab, Rawad, et al.
Publicado: (2023)

A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3
por: Tsuji, Shoji, et al.
Publicado: (2013)

Physiological Processes Modulated by the Chloride-Sensitive WNK-SPAK/OSR1 Kinase Signaling Pathway and the Cation-Coupled Chloride Cotransporters
por: Murillo-de-Ozores, Adrián Rafael, et al.
Publicado: (2020)

Melatonin modulates nitric oxide-regulated WNK-SPAK/OSR1-NKCC1 signaling in dorsal raphe nucleus of rats
por: Yang, Hye Jin, et al.
Publicado: (2021)

A patient with pseudohypoaldosteronism type II complicated by congenital hypopituitarism carrying a KLHL3 mutation
por: Mitani, Marie, et al.
Publicado: (2016)

THE WNK4/SPAK PATHWAY STIMULATES ALVEOLAR FLUID CLEARANCE BY UPREGULATION OF EPITHELIAL SODIUM CHANNEL IN MICE WITH LIPOPOLYSACCHARIDE-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME
por: Deng, Wang, et al.
Publicado: (2022)

NCC regulation by WNK signal cascade
por: Uchida, Shinichi, et al.
Publicado: (2023)

Evaluation of Phosphorylated Urinary Na-Cl Cotransporter Is Potentially Useful in a Patient With Pseudohypoaldosteronism Type II due to Mutation in CUL3
por: Nagahara, Keiko, et al.
Publicado: (2014)

A minor role of WNK3 in regulating phosphorylation of renal NKCC2 and NCC co-transporters in vivo
por: Oi, Katsuyuki, et al.
Publicado: (2011)

OSR1 and SPAK cooperatively modulate Sertoli cell support of mouse spermatogenesis
por: Liu, Yung-Liang, et al.
Publicado: (2016)

Pseudohypoaldosteronism Type II Caused by CUL3 Mutation Presented with Visual Impairment
por: Wang, Qiao, et al.
Publicado: (2018)

Zebrafish WNK Lysine Deficient Protein Kinase 1 (wnk1) Affects Angiogenesis Associated with VEGF Signaling
por: Lai, Ju-Geng, et al.
Publicado: (2014)

DNPEP is not the only peptidase that produces SPAK fragments in kidney
por: Koumangoye, Rainelli, et al.
Publicado: (2017)

A Rare Case of Pseudohypoaldosteronism Type II or Gordon Syndrome
por: Manas, F N U, et al.
Publicado: (2021)

Dietary salt with nitric oxide deficiency induces nocturnal polyuria in mice via hyperactivation of intrarenal angiotensin II-SPAK-NCC pathway
por: Sekii, Y., et al.
Publicado: (2022)

Dermal and Ophthalmic Findings in Pseudohypoaldosteronism
por: Korkut, Sabriye, et al.
Publicado: (2015)

Area under the curve analysis of blood pressure reveals increased spontaneous locomotor activity in SPAK knock‐in mice: relevance for hypotension induced by SPAK inhibition?
por: Burgess, Kieran, et al.
Publicado: (2019)

Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism
por: Szmigielska, Agnieszka
Publicado: (2022)

A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type II
por: Shao, Leping, et al.
Publicado: (2018)

Pseudohypoaldosteronism: case report and discussion of the syndrome.
por: Throckmorton, D. C., et al.
Publicado: (1991)

Hypercalcemia in an Infant With Pseudohypoaldosteronism Type 1
por: Jeng, Henry, et al.
Publicado: (2021)

Neonatal Pseudohypoaldosteronism Type-1 in Japan
por: Fujioka, Kazumichi, et al.
Publicado: (2022)

Challenges of Diagnosing Pseudohypoaldosteronism (PHA) in an Infant
por: Babar, Ghufran Saeed, et al.
Publicado: (2022)

Osmosensing by WNK Kinases
por: Akella, Radha, et al.
Publicado: (2021)

WNK1 regulates skeletal muscle cell hypertrophy by modulating the nuclear localization and transcriptional activity of FOXO4
por: Mandai, Shintaro, et al.
Publicado: (2018)

Errate: Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism
por: Szmigielska, Agnieszka
Publicado: (2023)

A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene
por: Lee, Se Eun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g6dl0a5q0i27sp36cgdr3rrqie